TY - JOUR
T1 - Myocardial ischemic events in 'real world' patients with atrial fibrillation treated with dabigatran or warfarin
T2 - A nationwide cohort study
AU - Larsen, Torben Bjerregaard
AU - Rasmussen, Lars Hvilsted
AU - Gorst-Rasmussen, Anders
AU - Skjøth, Flemming
AU - Rosenzweig, Mary
AU - Lane, Deirdre
AU - Lip, Gregory Y H
N1 - Copyright © 2013 Elsevier Inc. All rights reserved.
PY - 2014
Y1 - 2014
N2 - Dabigatran may provide less protection against myocardial infarction than vitamin K antagonists (VKAs) in patients with atrial fibrillation. This may be particularly evident among 'switchers' to dabigatran from VKA, as a result of discontinuation effects.
AB - Dabigatran may provide less protection against myocardial infarction than vitamin K antagonists (VKAs) in patients with atrial fibrillation. This may be particularly evident among 'switchers' to dabigatran from VKA, as a result of discontinuation effects.
U2 - 10.1016/j.amjmed.2013.12.005
DO - 10.1016/j.amjmed.2013.12.005
M3 - Journal article
C2 - 24361757
SN - 0002-9343
VL - 127
SP - 329
EP - 336
JO - American Journal of Medicine
JF - American Journal of Medicine
IS - 4
ER -